TITLE

The Future of Clinical Diagnostics

AUTHOR(S)
Santicerma, Anthony J.; Engelhart, Mark M.; Harvey, Michael H.
PUB. DATE
October 2004
SOURCE
Applied Clinical Trials;Oct2004 Supplement, Vol. 13, p6
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on the change in the drug development approaches and marketing strategy by pharmaceutical companies in the U.S. Impetus to the changes; Implications of generic drugs for the industry; Citations of the trends affecting the clinical diagnostics business.
ACCESSION #
14665920

 

Related Articles

  • Research & Markets: The Outlook for Pharmaceuticals Worldwide.  // Biomedical Market Newsletter;1/21/2012, Vol. 21, p1 

    The article informs that Research & Markets Ltd. has announced the inclusion of the report "The Outlook for Pharmaceuticals Worldwide" to their offering. It provides critical business insights to the prospects for, and risks in, leading pharmaceutical markets. It indicates that South Korea,...

  • HARD OF (AD) HERING. Koroneos, George // Pharmaceutical Executive;Aug2008, Vol. 29 Issue 8, p42 

    The article focuses on the efforts by pharmaceutical companies in the U.S. in implementing technologies and programs to help patients adhere to their drug regimens. Reminder messaging, nurse services and disease-state compliance programs are at the top of the companies' list of compliance...

  • Health Economics & Analysis in Clinical Development. Crown, William H.; Marshall, Deborah; Barr, Charles E. // Applied Clinical Trials;Feb2007, Vol. 16 Issue 2, p44 

    The article reports on the role of health data in drug development as the U.S. pharmaceutical industry faces serious financial challenges. It has been noted that pharmaceutical companies is rethinking new drug developments and marketing strategies in response to a health care system that is...

  • One Key Application: Analytics in Managed Markets.  // Pharmaceutical Executive;Oct2010, Vol. 30 Issue 10, p44 

    The article offers information on the Managed Market Analytics strategy that can be used by pharmaceutical companies to gain resource efficiency and operational capacity.

  • The One That Got Away. Paul, Reid // Pharmaceutical Representative;May2010, Vol. 40 Issue 5, p6 

    An introduction to the journal is presented where the editor discusses the journals' effort to promote sales representatives as a health care professional, the article "When the Bubble Burst," and a discussion on the marketing strategies in the pharmaceutical industry.

  • Drug chains a rock-solid beauty destination.  // Chain Drug Review;9/13/2010, Vol. 32 Issue 15, p25 

    The article reports that the back-to-school (B-T-S) campaign of chain drug retailers offers customer rewards, giving programs and health services to increase sales in New York.

  • Research & Markets: Drug Reconstitution at the Point-of-Care: Therapeutic Markets, Technologies, Strategies, and Prospects.  // Biomedical Market Newsletter;1/21/2012, Vol. 21, p1 

    The article informs that Research & Markets Ltd. has announced the inclusion of the "Drug Reconstitution at the Point-of-Care: Therapeutic Markets, Technologies, Strategies, and Prospects" to their offering. The report forecasts that with increase in biological drugs in terms of therapeutics and...

  • Research & Markets: South Korea: Pharmaceutical Industry Infrastructure Overview.  // Biomedical Market Newsletter;8/23/2011, Vol. 21, p345 

    The article focuses on the announcement of Research & Markets Ltd. that it has added the report "South Korea: Pharmaceutical Industry Infrastructure Overview" to their offerings. It states that the report examines pharmaceutical company market strategies and infrastructure. It mentions that the...

  • How Bayer Makes Decisions to Develop New Drugs. Stonebracker, Jeffrey S. // Interfaces;Nov/Dec2002, Vol. 32 Issue 6, p77 

    Drug development is time consuming, resource intensive, risky, and heavily regulated. To ensure that it makes the best drug-development decisions, Bayer Pharmaceuticals (Pharma) uses a structured process based on the principles of decision analysis to evaluate the technical feasibility and...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics